CoverScan
Multi-organ Assessment (e.g., Long COVID, Multi-morbidity)
CommercialActive
Key Facts
Indication
Multi-organ Assessment (e.g., Long COVID, Multi-morbidity)
Phase
Commercial
Status
Active
Company
About Perspectum Diagnostics
Perspectum is a commercial-stage diagnostics company specializing in quantitative MRI-based biomarkers for chronic diseases, primarily in hepatology and metabolic health. Its core platform, LiverMultiScan, and newer multi-organ product, CoverScan, provide non-invasive, quantitative assessments to replace or supplement invasive biopsies. The company leverages a strong research foundation from Oxford and has established commercial partnerships and a growing product portfolio aimed at enabling precision medicine. Recent leadership changes and strategic collaborations indicate a phase of operational evolution and market expansion.
View full company profile